Clinical Trial Update: Study of Liposomal Annamycin for the Treatment of Subjects with Soft-Tissue Sarcomas (STS) with Pulmonary Metastases [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2 study of liposomal annamycin for soft-tissue sarcoma with pulmonary metastases. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Metastasis
• Soft Tissue Sarcoma

Drugs mentioned

• Liposomal Annamycin (annamycin liposome)

Snippet

Sponsor: Moleculin Biotech, Inc. | Conditions: Sarcoma,Soft Tissue, Pulmonary Metastasis | Phase 1, Phase 2 | Status: COMPLETED